Pharming (PHAR) Other financing activities (2019 - 2025)
Pharming (PHAR) posted Other financing activities of -$285000.0 for Q4 2025, down 1576.47% on a QoQ basis from -$17000.0 in Q4 2024, and down 1576.47% year-over-year from $19302.8 in Q4 2024.
Pharming (PHAR) Other financing activities (2019 - 2025) Analysis & Trends
Pharming's Other financing activities history runs 7 years deep, the most recent figure standing at -$285000.0 for Q4 2025.
- Quarterly Other financing activities fell 1576.47% year-over-year to -$285000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$565000.0 (down 88.33% YoY) and the FY2025 annual result came in at -$285000.0, changed N/A from the prior year.
- Other financing activities was -$285000.0 for Q4 2025 at Pharming, down from -$17000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $253000.0 in Q3 2022 and bottomed at -$321000.0 in Q4 2021.
- A 5-year average of -$79413.8 and a median of -$33500.0 in 2022 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2022 — Other financing activities surged 1330.24% — and 2025, when it plunged 1576.47%.
- Pharming's Other financing activities stood at -$321000.0 in 2021, then jumped by 93.77% to -$20000.0 in 2022, then sank by 980.0% to -$216000.0 in 2023, then surged by 92.13% to -$17000.0 in 2024, then plunged by 1576.47% to -$285000.0 in 2025.
- Business Quant data shows PHAR's Other financing activities at -$285000.0 in Q4 2025, -$17000.0 in Q4 2024, and -$216000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Pharming | 9.02 Bn | 8.96 Bn | 65.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -285,000.00 |
| Dec 31, 2025 | -285,000.00 |
| Dec 31, 2024 | -17,000.00 |
| Dec 31, 2024 | -17,000.00 |
| Dec 31, 2023 | -216,000.00 |
| Dec 31, 2023 | -216,000.00 |
| Sep 30, 2023 | -47,000.00 |
| Sep 30, 2023 | -47,000.00 |
| Dec 31, 2022 | -20,000.00 |
| Dec 31, 2022 | -20,000.00 |
| Sep 30, 2022 | 253,000.00 |
| Sep 30, 2022 | 253,000.00 |
| Dec 31, 2021 | -321,000.00 |
| Dec 31, 2021 | -321,000.00 |
| Sep 30, 2021 | 17,689.31 |
| Sep 30, 2021 | 17,689.31 |
| Dec 31, 2020 | 1.08 Mn |
| Dec 31, 2020 | 1.08 Mn |
| Sep 30, 2020 | 1.19 Mn |
| Sep 30, 2020 | 1.19 Mn |